NASDAQ:EIGR - Eiger Biopharmaceuticals SEC Filings & 10K Form

$10.77
-0.43 (-3.84 %)
(As of 07/19/2019 04:00 PM ET)
Today's Range
$10.75
Now: $10.77
$11.26
50-Day Range
$9.48
MA: $10.68
$11.86
52-Week Range
$8.40
Now: $10.77
$15.33
Volume91,300 shs
Average Volume180,580 shs
Market Capitalization$207.43 million
P/E RatioN/A
Dividend YieldN/A
Beta1.07

SEC Filings

Eiger Biopharmaceuticals (NASDAQ:EIGR) SEC Filings

DateFilerForm TypeView
06/14/2019
3:26 PM
Broadfin Capital, LLC (Filed by)
Eiger Biopharmaceuticals (Subject)
Form SC 13G
View Filing
06/12/2019
3:33 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/30/2019
4:38 PM
Eiger Biopharmaceuticals (Issuer)
Sachdev Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/30/2019
4:35 PM
Eiger Biopharmaceuticals (Issuer)
Sachdev Amit (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
05/17/2019
3:15 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/09/2019
3:17 PM
Eiger Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
04/26/2019
3:54 PM
Cory David A (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/26/2019
3:34 PM
Eiger Biopharmaceuticals (Filer)
Form DEFA14A
View Filing
04/26/2019
3:31 PM
Eiger Biopharmaceuticals (Filer)
Form DEF 14A
View Filing
04/23/2019
5:53 PM
Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/22/2019
8:34 PM
Eiger Biopharmaceuticals (Issuer)
Ryali Sriram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/22/2019
8:34 PM
Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/22/2019
8:31 PM
Eiger Biopharmaceuticals (Issuer)
Patton Stephana Eilene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/22/2019
3:35 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/18/2019
3:32 PM
Eiger Biopharmaceuticals (Filer)
Form 424B5
View Filing
04/17/2019
3:07 PM
Eiger Biopharmaceuticals (Filer)
Form 424B5
View Filing
04/15/2019
3:16 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/26/2019
9:22 AM
Apelian David (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/26/2019
9:12 AM
Eiger Biopharmaceuticals (Issuer)
Shaffer James P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/26/2019
9:07 AM
Cory David A (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/26/2019
9:02 AM
Eiger Biopharmaceuticals (Issuer)
Murray Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/25/2019
9:00 PM
Eiger Biopharmaceuticals (Issuer)
Mayer Eldon C. III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/25/2019
8:53 PM
Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/25/2019
8:51 PM
Eiger Biopharmaceuticals (Issuer)
Glenn Jeffrey S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/25/2019
8:50 PM
Eiger Biopharmaceuticals (Issuer)
Loh Evan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/25/2019
8:46 PM
Eiger Biopharmaceuticals (Issuer)
Patton Stephana Eilene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/25/2019
8:45 PM
Eiger Biopharmaceuticals (Issuer)
Patton Stephana Eilene (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
03/14/2019
4:14 PM
Eiger Biopharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
03/08/2019
4:19 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/14/2019
3:25 PM
Eiger Biopharmaceuticals (Subject)
HBM Healthcare Investments Ltd. (0001232258) (Filed by)
Form SC 13G/A
View Filing
02/14/2019
2:30 PM
Eiger Biopharmaceuticals (Subject)
Vivo Ventures VI, LLC (Filed by)
Form SC 13D/A
View Filing
02/14/2019
1:27 PM
EcoR1 Capital, LLC (Filed by)
Eiger Biopharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/14/2019
8:08 AM
Eiger Biopharmaceuticals (Subject)
Prosight Management, LP (Filed by)
Form SC 13G/A
View Filing
02/13/2019
4:05 PM
Eiger Biopharmaceuticals (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Form SC 13G/A
View Filing
02/07/2019
7:40 AM
Eiger Biopharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
View Filing
02/06/2019
6:23 PM
Cory David A (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/06/2019
3:08 PM
Eiger Biopharmaceuticals (Subject)
INTERWEST PARTNERS X LP (Filed by)
Form SC 13D/A
View Filing
01/31/2019
11:16 AM
Eiger Biopharmaceuticals (Subject)
JENNISON ASSOCIATES LLC (Filed by)
Form SC 13G/A
View Filing
01/29/2019
2:23 PM
Eiger Biopharmaceuticals (Subject)
INTERWEST PARTNERS X LP (Filed by)
Form SC 13D/A
View Filing
01/09/2019
3:15 PM
Eiger Biopharmaceuticals (Issuer)
Murray Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/09/2019
3:12 PM
Eiger Biopharmaceuticals (Issuer)
Murray Christine (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
01/07/2019
3:05 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/04/2019
4:51 PM
Eiger Biopharmaceuticals (Issuer)
Ryali Sriram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/27/2018
1:12 PM
Eiger Biopharmaceuticals (Issuer)
Ryali Sriram (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
12/20/2018
7:29 PM
Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/10/2018
3:05 PM
Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/03/2018
4:26 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/30/2018
1:26 PM
Eiger Biopharmaceuticals (Issuer)
Mayer Eldon C. III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/28/2018
7:51 PM
Eiger Biopharmaceuticals (Issuer)
Mayer Eldon C. III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/09/2018
3:01 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/26/2018
2:11 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Eiger Biopharmaceuticals (Subject)
Form SC 13G
View Filing
10/25/2018
4:20 PM
Eiger Biopharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
10/25/2018
4:19 PM
Eiger Biopharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G
View Filing
10/24/2018
5:07 AM
Eiger Biopharmaceuticals (Subject)
INTERWEST PARTNERS X LP (Filed by)
Form SC 13D/A
View Filing
10/23/2018
4:21 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/23/2018
4:12 PM
Eiger Biopharmaceuticals (Filer)
Form 424B5
View Filing
10/22/2018
3:50 PM
Eiger Biopharmaceuticals (Filer)
Form 424B5
View Filing
10/22/2018
3:33 PM
Desai Keval (Reporting)
Eiger Biopharmaceuticals (Issuer)
InterWest Management Partners X, LLC (Reporting)
INTERWEST PARTNERS X LP (Reporting)
Kliman Gilbert H (Reporting)
NASR KHALED (Reporting)
ORONSKY ARNOLD L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/22/2018
3:03 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/20/2018
11:48 AM
Eiger Biopharmaceuticals (Filer)
Form CT ORDER
View Filing
08/16/2018
3:18 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/13/2018
3:48 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/10/2018
6:31 AM
Eiger Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
06/11/2018
4:14 PM
Eiger Biopharmaceuticals (Filer)
Form DEFA14A
View Filing
06/04/2018
3:03 PM
EcoR1 Capital, LLC (Filed by)
Eiger Biopharmaceuticals (Subject)
Form SC 13G
View Filing
05/25/2018
3:43 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/25/2018
3:41 PM
Eiger Biopharmaceuticals (Filer)
Form 424B5
View Filing
05/23/2018
4:23 PM
Eiger Biopharmaceuticals (Filer)
Form 424B5
View Filing
05/23/2018
3:00 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/16/2018
7:16 AM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/11/2018
4:21 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/26/2018
4:25 PM
Eiger Biopharmaceuticals (Filer)
Form DEFA14A
View Filing
04/26/2018
4:21 PM
Eiger Biopharmaceuticals (Filer)
Form DEF 14A
View Filing
04/04/2018
4:18 PM
Eiger Biopharmaceuticals (Issuer)
Quan Joanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/16/2018
7:26 PM
Eiger Biopharmaceuticals (Issuer)
Glenn Jeffrey S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/16/2018
7:25 PM
Eiger Biopharmaceuticals (Issuer)
Loh Evan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/16/2018
7:24 PM
Eiger Biopharmaceuticals (Issuer)
Mayer Eldon C. III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/16/2018
7:23 PM
Dietz Thomas John (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/16/2018
7:20 PM
Apelian David (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/16/2018
7:19 PM
Cory David A (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/16/2018
7:17 PM
Eiger Biopharmaceuticals (Issuer)
Shaffer James P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/16/2018
7:16 PM
Eiger Biopharmaceuticals (Issuer)
Quan Joanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/16/2018
7:14 PM
Eiger Biopharmaceuticals (Issuer)
WELCH JAMES H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/16/2018
4:15 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/22/2018
5:11 AM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/13/2018
11:40 AM
Eiger Biopharmaceuticals (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Form SC 13G/A
View Filing
02/05/2018
1:34 PM
Eiger Biopharmaceuticals (Subject)
JENNISON ASSOCIATES LLC (Filed by)
Form SC 13G
View Filing
01/22/2018
7:51 AM
Eiger Biopharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G
View Filing
01/18/2018
3:15 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/09/2018
5:11 PM
Eiger Biopharmaceuticals (Issuer)
Mayer Eldon C. III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/09/2018
5:03 PM
Eiger Biopharmaceuticals (Issuer)
Mayer Eldon C. III (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
01/09/2018
4:52 PM
Apelian David (Reporting)
Eiger Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2018
3:09 PM
Eiger Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/20/2017
11:15 PM
Eiger Biopharmaceuticals (Filer)
Form EFFECT
View Filing
12/11/2017
7:15 AM
Eiger Biopharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
View Filing
This page was last updated on 7/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel